Isikhokelo soMyalelo we-Thyroid Hormone Replacement Drugs
I-thyroid ingaba yinto engasebenzi - imeko eyaziwa ngokuba yi-hypothyroidism - ngenxa yesifo seHashimoto, imithi ethile okanye ezinye izinto. Ukwelashwa kwe-iodine ye-iodine yeSifo se-Graves kunye ne-hyperthyroidism kunokushiya i-thyroid engasebenzi-okanye ivalwe ngokupheleleyo. Kwezinye iimeko, ukususwa kokugonywa (thyroidectomy) kwenziwa njengonyango lomhlaza we-thyroid, i-goiter (i-thyroid eyandisiweyo), okanye ngokuqhelekileyo, i-hyperthyroidism. Kwezinye iimeko, iintsana zizalwe nge-thyroid okanye i-thyroid engasebenzi - imeko eyaziwayo njenge-congenital hypothyroidism.
Kuzo zonke iimeko, unyango lwe-thyroid engasebenzi phantsi, uvale iglovu, ugqithwe ngokugqithisileyo okanye isifo se-congenitally sinokukhutshwa kwe-hormone ye-thyroid ngokuchithwa kwemithi ye-thyroid.
Oku kulandelayo kukugqithisileyo kwimizi ephezulu ye-hormone ye-hormone.
Levothyroxine (i-Thyroxine / i-T4)
Phakathi kwamagqirha aqhelekileyo, i-hormone ye-thyroid eyimveliso eyaziwayo kunye neqhelekileyo eqhelekileyo i-levothyroxine, uhlobo oluthile lwe-thyroxine (i-hormone ye-thyroid igqityiwe njengeT4). U-Levothyroxine ubizwa nangokuthi l-thyroxine, kunye ne-L-T4.
EUnited States, i-levothyroxine ifumaneka njenge-levothyroxine yesizukulwana, kunye ne-Synthroid, i-Levothroid, kunye ne-Levoxyl yamagama amacwecwe e-levothyroxine. I-Tirosint yindlela ye-gelcap yamanzi e-levothyroxine eye kwivenkile ukususela ngo-2011.
KwiChanada, i-Synthroid, i-Eltroxin, kunye ne-PMS-i-Levothyroxine ngamagama atshwayo.
Oogqirha abaninzi abacebisi i-levothyroxine . Amagama ebhanti akhethiweyo, kwaye i-brand nganye ibhekwa ngokufanelekileyo ngokulinganayo.
I-Liothyronine (Synthetic Triiodothyronine / T3)
I-thyroxine kunye ne-triiodothyronine (T3), i-hormone ye-thyroid. I-Liothyronine yindlela yokwenza i-T3, kwaye ifumaneka kwifom efakwe njenge-brand Cytomel, kunye ne-generic liothyronine. I-T3 inokuqulunqwa.
Kwiminyaka yakutshanje, abanye oogqirha baye bamisela i-T3 ngaphezu kwe-T4. Olunye uvavanyo luka-2009 lubonise ukuba uninzi lwezigulane zikhetha i-levothyroxine kunye ne-T3 xa kuthelekiswa ne-levothyroxine kuphela yonyango.
Uphando oluvelele olupapashwe kwi- New England Journal of Medicine lubonise ukuba izigulane zizuze kwi-T4 / T3 yonyango . Olunye uphando luye lwahluleka ukubonisa inzuzo kunye nokusetyenziswa kweT4 / T3 unyango oluhlangeneyo luhlala luphikisana.
Isixhobo esinezixhobo ezenziweyo ze-T3, i- Thyromax , sisetyenzisweni zonyango kwaye siyavavanywa ukuze kuhanjiswe kwaye kusasazwe e-US
Ukuchazwa kwendalo yeTyroid
I-thyroid echithwe ngokwemvelo - ngamanye amaxesha agqityiweyo i-NDT-isilwanyana esilungiselelwe kwi-porcins eyomileyo (ihagu). I-thyroid echithwe ngokwemvelo yilezi zixhobo zonyango ezifumaneka kwii-1900 zakudala, phantsi kwegama legama leMpahla yeTyroid, kwada kwafika i-levothyroxine kuma-1950.
I-thyroid yezemvelo yaba yinto enqwenelekayo njengoko umkhiqizo wokwenziwa komsebenzi wenziwa njengamaxesha amanamhlanje kwaye azinzile. Ukususela ngo-1990, ke, i-thyroid ekhethiweyo ivuyiswe ngokutsha, ikakhulukazi oogqirha abadala abaqhelana nezilwanyana, kunye neengcali ezixhomekeke kuzo zonke izigulana ezithi zixazulule izibonakaliso ezingcono kuneziyobisi zonyango kwezinye izigulane zabo.
Namhlanje, iimpawu ezininzi ze-thyroid ezichongiweyo ziyafumaneka kwi-US nakwezinye iindawo, nge-prescription, kuquka i-Naturethroid, i-WP ye-Thyroid, i- Armor ye-Thyroid , i-NP ye-Nroid ye-generic (eyenziwe ngumenzi we-Acella) kunye ne-Canadi ye-natural thyroid evela kumenzi we-Erfa.
Liotrix (Synthetic Thyroxine / Triiodothyronine T4 / T3 Inhlanganisela)
I-Liotrix yayiyinhlanganisela yokwenziwa kwe-thyroxine kunye ne-triiodothyronine (i-T4 ne-T3). Kwiminyaka yakutshanje, i-liotrix yayifumaneka kwifomu eyenziweyo, eyaziwa ngegama legama le-Thyrolar, kwi-Forest Labs. Kodwa i-Thyrolar sele isuka kwimarike iminyaka emininzi, kwaye ayisasetyenziswa okanye isetyenziswe.
> Imithombo:
> Braverman, MD, Lewis E., noRobert D. Utiger, MD. UWerner no-Ingbar I-Thyroid: Isicatshulwa esibalulekileyo kunye neZiklinikhi. 9 >> . Philadelphia: Lippincott Williams & Wilkins (LWW), 2005.